A multiple-targets alkaloid nuciferine overcomes paclitaxel-induced drug resistance in vitro and in vivo
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Phytomedicine
- Vol. 79, 153342
Abstract
No abstract availableKeywords
Funding Information
- Fundo para o Desenvolvimento das Ciências e da Tecnologia
This publication has 41 references indexed in Scilit:
- Collateral sensitivity as a strategy against cancer multidrug resistanceDrug Resistance Updates, 2012
- The controversial role of ABC transporters in clinical oncologyEssays in Biochemistry, 2011
- Expression of ABCG2 (BCRP) Is Regulated by Nrf2 in Cancer Cells That Confers Side Population and Chemoresistance PhenotypeMolecular Cancer Therapeutics, 2010
- Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2Carcinogenesis, 2008
- Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoproteinMolecular Cancer Therapeutics, 2007
- A high nuclear basal level of ERK2 phosphorylation contributes to the resistance of cisplatin-resistant human ovarian cancer cellsGynecologic Oncology, 2007
- Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination StudiesPharmacological Reviews, 2006
- ROLE OF ABCG2/BCRP IN BIOLOGY AND MEDICINEAnnual Review of Pharmacology and Toxicology, 2006
- Inhibition of Phosphorylation of BAD and Raf-1 by Akt Sensitizes Human Ovarian Cancer Cells to PaclitaxelJournal of Biological Chemistry, 2002
- Multidrug resistance (MDR) in cancerEuropean Journal of Pharmaceutical Sciences, 2000